Picture of Vitaspring Biomedical Co. logo

VSBC Vitaspring Biomedical Co. Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Vitaspring Biomedical Co., fiscal year end - January 31st, USD millions except per share, conversion factor applied.

2020
January 31st
2021
January 31st
C2022
January 31st
2023
January 31st
2024
January 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments00.0450.1070.030
Net Total Accounts Receivable
Net Total Receivables2.950.380
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets00.1893.060.4370.024
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment00.5250.3050.114
Other Long Term Assets
Total Assets00.1893.60.7660.137
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities00.0931.743.073.49
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities00.0932.033.163.49
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity00.0961.58-2.4-3.35
Total Liabilities & Shareholders' Equity00.1893.60.7660.137
Total Common Shares Outstanding